Atlas Trials

Red Cell Distribution Width Versus Presepsin (Soluble CD14) as a Prognostic Marker in Critically-ill Sepsis Patients

Clinical trial NCT03796715 · COMPLETED

Trial details

NCT number
NCT03796715
Sponsor
Ain Shams University
Status
COMPLETED
Study type
OBSERVATIONAL
Sepsis
Start date
2018-08-01
Primary completion
2018-11-20
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.